Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

165.98
+1.490.91%
Post-market: 166.110.1300+0.08%19:53 EDT
Volume:3.18M
Turnover:527.99M
Market Cap:257.43B
PE:24.85
High:167.25
Open:164.04
Low:163.96
Close:164.49
52wk High:212.71
52wk Low:145.79
Shares:1.55B
Float Shares:1.50B
Volume Ratio:0.84
T/O Rate:0.21%
Dividend:3.23
Dividend Rate:1.95%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.02%
PB:5.12
PE(LYR):25.38

Loading ...

AstraZeneca Sees 2030 Goal on Track as Cancer Drugs Drive Growth

Dow Jones
·
Jul 27

Press Release: AstraZeneca Results: H1 and Q2 2026

Dow Jones
·
Jul 27

AstraZeneca ‘on track’ to deliver ambition of $80B in revenue in 2030

TIPRANKS
·
Jul 27

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Jul 27

Stocks to Watch: CXMT, LVMH, Nvidia, Chevron

Dow Jones
·
Jul 27

Astrazeneca's Ultomiris Misses Primary Goal in Late-Stage Rare-Disease Trial

MT Newswires Live
·
Jul 27

AstraZeneca Reports 'Positive' Phase 3 Results for Sonesitatug Vedotin in Claudin 18.2-Positive Gastric Cancers

MT Newswires Live
·
Jul 27

AstraZeneca Q2 Core Earnings, Revenue Rise

MT Newswires Live
·
Jul 27

AstraZeneca Results Should Allay Investor Fears

Dow Jones
·
Jul 27

AstraZeneca Beats Q2 Earnings Estimates, Focus Shifts to Next-Generation Oncology Drug Pipeline

Stock News
·
Jul 27

AstraZeneca Q2 Adj. EPS $2.63 Beats $2.48 Estimate, Sales $15.384B Miss $15.459B Estimate

Benzinga Earnings
·
Jul 27

AstraZeneca Beats Second-Quarter Profit Expectations, Holds Outlook

Reuters
·
Jul 27

Movement Alert|AstraZeneca PLC Rises 5.33% Overnight, Q2 Earnings Beat Market Expectations

Market Focus
·
Jul 27

Astrazeneca Q2 Revenue Rises 6% on Demand for Its Cancer Therapies

Reuters
·
Jul 27

Astrazeneca PLC Stock Rises Friday, Underperforms Market

Dow Jones
·
Jul 25

Astrazeneca's Drug Pipeline in Focus After Recent Trial Miss

Dow Jones
·
Jul 24

AstraZeneca, Daiichi Sankyo's Enhertu Combination Therapy Recommended for EU Approval in Breast Cancer

MT Newswires Live
·
Jul 24

AstraZeneca's Trixeo Recommended for EU Approval to Treat Asthma

MT Newswires Live
·
Jul 24

AstraZeneca, Daiichi’s Enhertu with pertuzumab recommended for approval in EU

TIPRANKS
·
Jul 24

AstraZeneca announces Trixeo Aerosphere recommended for approval in EU

TIPRANKS
·
Jul 24